Skip to content

Clinical trials

Withdrawn Phase 1/2 COVID-19 trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Phase: Phase 1/2 Status: Withdrawn Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20205
20218
20226
20232
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ImmunityBio, Inc.2
Sorrento Therapeutics, Inc.2
Stanford University2
Aivita Biomedical, Inc.1
Attgeno AB1
Aveni Foundation1
Baylx Inc.1
Beth Israel Deaconess Medical Center1
Bio-Thera Solutions1
Direct Biologics, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-1924
Respiratory Distress Syndrome3
Acute Lung Injury1
Coronavirus Infections1
Cytokine Release Syndrome1
Dyspnea1
Hemostatic Disorders1
Hypertension, Pulmonary1
Respiratory Insufficiency1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.